pharma news today obesity drugs glp-1 october 2025 Agonists Weight Loss Market Report, 2025-2030 GLP-1 Agonists Weight Loss Drugs
Description
This product is not intended to diagnose, treat, cure, or prevent any disease
This patch helps suppress appetite, supporting portion control and reducing the temptation to overeat
Not intended for use if you are pregnant or nursing
The incretin hormone glucagon-like peptide 1 (GLP-1) has been implicated in the gutrenal axis and incretin-based therapies might reduce the burden of diabetic kidney disease
